Enzymes governing glycolytic flux in CRC cells exhibit crosstalk with TME dynamics, while EMP inhibitors demonstrate potential to mitigate treatment resistance to radiotherapy and chemotherapy. This evidence concerns the gene MAEA and colorectal carcinoma.